Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma (Q44926804)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma
scientific article

    Statements

    Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit